Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Haywood Securities is a prominent Canadian independent investment dealer that provides investment banking, equity research, and sales and trading services. Founded in 1981, the firm is 100% employee-owned and maintains a significant focus on the life sciences, mining, energy, and technology sectors. Through its Haywood Capital Markets division and various subsidiaries like Haywood Capital Partners, the company facilitates capital raising, mergers and acquisitions, and strategic advisory for emerging and mid-market biotech and healthcare companies. Haywood is well-regarded for its specialized life sciences research team, which covers a broad range of public and private companies in the biotechnology and medical technology industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Haywood Capital Partners.